Cargando…

Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC)

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common primary liver cancer arising from the liver cells, hepatocytes. Chronic liver inflammation plays a key role in the development of HCC. HCC is a highly fatal disease where race/ethnicity plays a vital role in determining incidence, mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Reghupaty, Saranya Chidambaranathan, Kanwal, Sadia, Mendoza, Rachel G., Davis, Eva, Li, Haiwen, Lai, Zhao, Dozmorov, Mikhail G., Faison, Milton Omar, Siddiqui, Rafat Ali, Sarkar, Devanand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486472/
https://www.ncbi.nlm.nih.gov/pubmed/37686559
http://dx.doi.org/10.3390/cancers15174283
_version_ 1785103014669844480
author Reghupaty, Saranya Chidambaranathan
Kanwal, Sadia
Mendoza, Rachel G.
Davis, Eva
Li, Haiwen
Lai, Zhao
Dozmorov, Mikhail G.
Faison, Milton Omar
Siddiqui, Rafat Ali
Sarkar, Devanand
author_facet Reghupaty, Saranya Chidambaranathan
Kanwal, Sadia
Mendoza, Rachel G.
Davis, Eva
Li, Haiwen
Lai, Zhao
Dozmorov, Mikhail G.
Faison, Milton Omar
Siddiqui, Rafat Ali
Sarkar, Devanand
author_sort Reghupaty, Saranya Chidambaranathan
collection PubMed
description SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common primary liver cancer arising from the liver cells, hepatocytes. Chronic liver inflammation plays a key role in the development of HCC. HCC is a highly fatal disease where race/ethnicity plays a vital role in determining incidence, mortality and survival rates. There is a knowledge gap in our understanding of the molecular mechanism underlying the HCC racial disparity between African-American (AA)/Black and White patients. Global gene expression analysis between AA/Black and White HCC patients identified the activation of a key inflammatory pathway in AA/Black tumors. Ginger extract (GE) is known for its anti-inflammatory properties. GE inhibited proliferation of HCC cells, and our data suggest that HCC cell lines from AA/Black patients responded better to GE compared to those from White and Asian patients. These findings suggest that AA/Black HCC patients might benefit from holistic dietary approach which includes ginger. ABSTRACT: African-American (AA)/Black hepatocellular carcinoma (HCC) patients have increased incidence and decreased survival rates compared to non-Hispanic (White) patients, the underlying molecular mechanism of which is not clear. Analysis of existing RNA-sequencing (RNA-seq) data in The Cancer Genome Atlas (TCGA) and in-house RNA-sequencing of 14 White and 18 AA/Black HCC patients revealed statistically significant activation of type I interferon (IFN-I) signaling pathway in AA/Black patients. A four-gene signature of IFN-stimulated genes (ISGs) showed increased expression in AA/Black HCC tumors versus White. HCC is a disease of chronic inflammation, and IFN-Is function as pro-inflammatory cytokines. We tested efficacy of ginger extract (GE), a dietary compound known for anti-inflammatory properties, on HCC cell lines derived from White (HepG2), AA/Black (Hep3B and O/20) and Asian (HuH-7) patients. GE exhibited a significantly lower IC(50) on Hep3B and O/20 cells than on HepG2 and HuH-7 cells. The GE treatment inhibited the activation of downstream mediators of IFN-I signaling pathways and expression of ISGs in all four HCC cells. Our data suggest that ginger can potentially attenuate IFN-I-mediated signaling pathways in HCC, and cells from AA/Black HCC patients may be more sensitive to ginger. AA/Black HCC patients might benefit from a holistic diet containing ginger.
format Online
Article
Text
id pubmed-10486472
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104864722023-09-09 Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC) Reghupaty, Saranya Chidambaranathan Kanwal, Sadia Mendoza, Rachel G. Davis, Eva Li, Haiwen Lai, Zhao Dozmorov, Mikhail G. Faison, Milton Omar Siddiqui, Rafat Ali Sarkar, Devanand Cancers (Basel) Article SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common primary liver cancer arising from the liver cells, hepatocytes. Chronic liver inflammation plays a key role in the development of HCC. HCC is a highly fatal disease where race/ethnicity plays a vital role in determining incidence, mortality and survival rates. There is a knowledge gap in our understanding of the molecular mechanism underlying the HCC racial disparity between African-American (AA)/Black and White patients. Global gene expression analysis between AA/Black and White HCC patients identified the activation of a key inflammatory pathway in AA/Black tumors. Ginger extract (GE) is known for its anti-inflammatory properties. GE inhibited proliferation of HCC cells, and our data suggest that HCC cell lines from AA/Black patients responded better to GE compared to those from White and Asian patients. These findings suggest that AA/Black HCC patients might benefit from holistic dietary approach which includes ginger. ABSTRACT: African-American (AA)/Black hepatocellular carcinoma (HCC) patients have increased incidence and decreased survival rates compared to non-Hispanic (White) patients, the underlying molecular mechanism of which is not clear. Analysis of existing RNA-sequencing (RNA-seq) data in The Cancer Genome Atlas (TCGA) and in-house RNA-sequencing of 14 White and 18 AA/Black HCC patients revealed statistically significant activation of type I interferon (IFN-I) signaling pathway in AA/Black patients. A four-gene signature of IFN-stimulated genes (ISGs) showed increased expression in AA/Black HCC tumors versus White. HCC is a disease of chronic inflammation, and IFN-Is function as pro-inflammatory cytokines. We tested efficacy of ginger extract (GE), a dietary compound known for anti-inflammatory properties, on HCC cell lines derived from White (HepG2), AA/Black (Hep3B and O/20) and Asian (HuH-7) patients. GE exhibited a significantly lower IC(50) on Hep3B and O/20 cells than on HepG2 and HuH-7 cells. The GE treatment inhibited the activation of downstream mediators of IFN-I signaling pathways and expression of ISGs in all four HCC cells. Our data suggest that ginger can potentially attenuate IFN-I-mediated signaling pathways in HCC, and cells from AA/Black HCC patients may be more sensitive to ginger. AA/Black HCC patients might benefit from a holistic diet containing ginger. MDPI 2023-08-27 /pmc/articles/PMC10486472/ /pubmed/37686559 http://dx.doi.org/10.3390/cancers15174283 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Reghupaty, Saranya Chidambaranathan
Kanwal, Sadia
Mendoza, Rachel G.
Davis, Eva
Li, Haiwen
Lai, Zhao
Dozmorov, Mikhail G.
Faison, Milton Omar
Siddiqui, Rafat Ali
Sarkar, Devanand
Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC)
title Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC)
title_full Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC)
title_fullStr Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC)
title_full_unstemmed Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC)
title_short Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC)
title_sort dysregulation of type i interferon (ifn-i) signaling: a potential contributor to racial disparity in hepatocellular carcinoma (hcc)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486472/
https://www.ncbi.nlm.nih.gov/pubmed/37686559
http://dx.doi.org/10.3390/cancers15174283
work_keys_str_mv AT reghupatysaranyachidambaranathan dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc
AT kanwalsadia dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc
AT mendozarachelg dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc
AT daviseva dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc
AT lihaiwen dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc
AT laizhao dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc
AT dozmorovmikhailg dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc
AT faisonmiltonomar dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc
AT siddiquirafatali dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc
AT sarkardevanand dysregulationoftypeiinterferonifnisignalingapotentialcontributortoracialdisparityinhepatocellularcarcinomahcc